Laurion Capital Management LP Bicycle Therapeutics PLC Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$40.12 - $59.5 $1.26 Million - $1.87 Million	-31,410 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.7 - $61.14 $155,707 - $228,296	-3,734 Reduced 10.62%	31,410 $1.91 Million
Q3 2021 Nov 15, 2021	SELL	$27.95 - $44.24 $409,411 - $648,027	-14,648 Reduced 29.42%	35,144 $1.46 Million
Q2 2021 Aug 13, 2021	SELL	$27.0 - $32.28 $218,700 - $261,468	-8,100 Reduced 13.99%	49,792 $1.51 Million
Q1 2020 May 14, 2020	SELL	$9.82 - $18.0 $161,028 - $295,164	-16,398 Reduced 22.07%	57,892 $868,000
Q4 2019 Feb 13, 2020	SELL	$7.68 - $11.08 $125,521 - $181,091	-16,344 Reduced 18.03%	74,290 $701,000
Q3 2019 Nov 13, 2019	SELL	$6.74 - $12.01 $63,126 - $112,485	-9,366 Reduced 9.37%	90,634 $1.03 Million
Q2 2019 Aug 13, 2019	BUY	$10.06 - $14.63 $1.01 Million - $1.46 Million	100,000 New	100,000 $1.01 Million

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.